Key facts
- Scanbase’s last known valuation is $7.1M (Jan 2023).
- It has raised $5.0M; the latest was Early Stage VC ($2.5M) in Oct 2025.
- Notable investors include Y Combinator, Liquid 2 Ventures, Rebel Fund, TRAC VC, Lobster Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Scanbase
- ·The full record, as it builds
Funding rounds
No funding rounds for Scanbase are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scanbase
Provider of services in the healthcare sector intended to convert photos of rapid diagnostic tests into positive or negative results. The company offers algorithm design, system integration, equipment modernization, consulting services, implementation services, and support services, providing healthcare organizations with access to services to optimize diagnostic operations.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2022
- Employees
- 10
- Website
- scanbase.com/
- Ownership
- Privately Held (backing)
Scanbase doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scanbase shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scanbase in its N-PORT filings yet. We sweep new filings monthly.